Results from the Phase III MARIPOSA study found that the combination therapy showed an 8% improvement in overall survival in ...

By embracing this leadership approach, clinical research stakeholders can prioritize more effective staff training and ...

Improving accessibility drives faster and more efficient patient enrollment and a more diverse trial population.

Potential first-in-class B7-H3 directed antibody drug conjugate ifinatamab deruxtecan shows potential to improve outcomes for ...

In a fireside chat with ACT editor Andy Studna, Burks, vice president, site solutions highlights her career path and streamlining workflows between sites and sponsors.

Regulators play a vitally important role that’s evolving in real-time. In 2023, Congress passed requirements in the Food and Drug Omnibus Reform Act that require drug and medical device manufacturers ...

Across two clinical trials in the QWINT program, efsitora showed non-inferior A1C reduction compared to other frequently used ...

In the final part of this video interview, Jim Murphy, CEO of Greenphire discusses the role of artificial intelligence, using ...

Aixial, a contract research organization, will migrate data onto the Medidata Platform to streamline access.

While measuring and managing site costs can be challenging, these codes can aid in accounting for labor expenses, budgeting ...

Study findings suggest that most qualitative systemic reviews implement a generic approach as opposed to focusing on equity, ...

Johnson & Johnson has announced the submission of a Biologics License Application (BLA) to the FDA for nipocalimab. This ...